ARCHIVES

Senate Approves Supplemental Funds For NIH and FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 20 | May 23, 2008

Download PDF Visit The Full Archive

Related Articles

Diet Intervention Results Could Be Found In Months

April 4, 1986

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

July 21, 2006